Advanced search
Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 26, 1996 - Issue 7
Submit an article Journal homepage
200
Views
205
CrossRef citations to date
0
Altmetric
Research Article

Specificity of substrate and inhibitor probes for cytochrome P450s: evaluation of in vitro metabolism using cDNA-expressed human P450s and human liver microsomes

S. Ono Central Laboratory for Research and Development, Amersham K.K., 2802–1, Hiratsuka, Shiroi-machi, Inba-gun, Chiba, 270–14, Japan; Laboratory of Biochemical Pharmacology and Biotoxicology, Faculty of Pharmaceutical Sciences, Chiba University, Japan
,
T. Hatanaka Central Laboratory for Research and Development, Amersham K.K., 2802–1, Hiratsuka, Shiroi-machi, Inba-gun, Chiba, 270–14, Japan
,
H. Hotta Central Laboratory for Research and Development, Amersham K.K., 2802–1, Hiratsuka, Shiroi-machi, Inba-gun, Chiba, 270–14, Japan
,
T. Satoh Laboratory of Biochemical Pharmacology and Biotoxicology, Faculty of Pharmaceutical Sciences, Chiba University, Japan
,
F. J. Gonzalez Laboratory of Molecular Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, MD, 32, USA
&
M. Tsutsui Central Laboratory for Research and Development, Amersham K.K., 2802–1, Hiratsuka, Shiroi-machi, Inba-gun, Chiba, 270–14, Japan
Pages 681-693 | Received 29 Nov 1995, Published online: 22 Sep 2008

Citations (205)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (48)

Marycarmen Cruz-Hurtado, Ma de Lourdes López-González, Victor Mondragón & Adolfo Sierra-Santoyo. (2019) In vitro phase I metabolism of vinclozolin by human liver microsomes. Xenobiotica 49:8, pages 895-904.
Read now
Ricardo Jorge Dinis-Oliveira. (2017) Metabolic profile of oxazepam and related benzodiazepines: clinical and forensic aspects. Drug Metabolism Reviews 49:4, pages 451-463.
Read now
Francesca Toselli, Peter R. Dodd & Elizabeth M. J. Gillam. (2016) Emerging roles for brain drug-metabolizing cytochrome P450 enzymes in neuropsychiatric conditions and responses to drugs. Drug Metabolism Reviews 48:3, pages 379-404.
Read now
Da-Peng Dai, Li-Ming Hu, Pei-Wu Geng, Shuang-Hu Wang, Jie Cai, Guo-Xin Hu & Jian-Ping Cai. (2015) In vitro functional analysis of 24 novel CYP2C19 variants recently found in the Chinese Han population. Xenobiotica 45:11, pages 1030-1035.
Read now
Seigo Sanoh, Yoichi Naritomi, Mami Fujimoto, Koya Sato, Akio Kawamura, Aya Horiguchi, Kazumi Sugihara, Yaichiro Kotake, Hiroki Ohshita, Chise Tateno, Toru Horie, Shigeyuki Kitamura & Shigeru Ohta. (2015) Predictability of plasma concentration–time curves in humans using single-species allometric scaling of chimeric mice with humanized liver. Xenobiotica 45:7, pages 605-614.
Read now
Susan S. Schiffman & Kristina I. Rother. (2013) Sucralose, A Synthetic Organochlorine Sweetener: Overview Of Biological Issues. Journal of Toxicology and Environmental Health, Part B 16:7, pages 399-451.
Read now
Shu-Feng Zhou, Jun-Ping Liu & Balram Chowbay. (2009) Polymorphism of human cytochrome P450 enzymes and its clinical impact. Drug Metabolism Reviews 41:2, pages 89-295.
Read now
A. Messina, V. Chirulli, P. G. Gervasi & V. Longo. (2008) Purification, molecular cloning, heterologous expression and characterization of pig CYP1A2. Xenobiotica 38:12, pages 1453-1470.
Read now
N. Araki, S. Tsuruoka, N. Wang, G. Hasegawa, H. Yanagihara, H. Ando, T. Omasa, S. Enosawa, H. Nagai & A. Fujimura. (2008) Human CYP3A4-introduced HepG2 cells: screening system of new chemicals for the evaluation of CYP3A4-inhibiting activity. Xenobiotica 38:11, pages 1355-1364.
Read now
N. Kanayama, C. Kanari, Y. Masuda, S. Ohmori & T. Ooie. (2007) Drug–drug interactions in the metabolism of imidafenacin: Role of the human cytochrome P450 enzymes and UDP-glucuronic acid transferases, and potential of imidafenacin to inhibit human cytochrome P450 enzymes. Xenobiotica 37:2, pages 139-154.
Read now
Yasuhiro Masubuchi & Toshiharu Horie. (2007) Toxicological Significance of Mechanism-Based Inactivation of Cytochrome P450 Enzymes by Drugs. Critical Reviews in Toxicology 37:5, pages 389-412.
Read now
Michael R. Franklin & Jonathan E. Constance. (2007) Comparative 1-Substituted Imidazole Inhibition of Cytochrome P450 Isozyme-Selective Activities in Human and Mouse Hepatic Microsomes. Drug Metabolism Reviews 39:2-3, pages 309-322.
Read now
M. D. Lee, E. Ayanoglu & L. Gong. (2006) Drug-induced changes in P450 enzyme expression at the gene expression level: A new dimension to the analysis of drug–drug interactions. Xenobiotica 36:10-11, pages 1013-1080.
Read now
M. Miura, K. Otani & T. Ohkubo. (2005) Identification of human cytochrome P450 enzymes involved in the formation of 4-hydroxyestazolam from estazolam. Xenobiotica 35:5, pages 455-465.
Read now
Petr Hodek, Lucie Bořek-Dohalská, Bruno Sopko, Miroslav Šulc, Stanislav Smrček, Jiří Hudeček, Josef Janků & Marie Stiborová. (2005) Structural requirements for inhibitors of cytochromes P450 2B: Assessment of the enzyme interaction with diamondoids. Journal of Enzyme Inhibition and Medicinal Chemistry 20:1, pages 25-33.
Read now
M.‐L. Laakso, N. Lindblom, P. Kaipainen & M. Kaski. (2005) Urinary 6‐hydroxymelatonin sulfate excretion in intellectually disabled subjects with sleep disorders and multiple medications: Validation of measurements in urine extracted from diapers. Scandinavian Journal of Clinical and Laboratory Investigation 65:5, pages 413-432.
Read now
Patrick L. Sheets & Gary P. Carlson. (2004) Kinetic Factors Involved in the Metabolism of Benzene in Mouse Lung and Liver. Journal of Toxicology and Environmental Health, Part A 67:5, pages 421-430.
Read now
Jacob J. Briedé, Roger W.L. Godschalk, Marijn T.G. Emans, Theo M.C.M. de Kok, Ebienus van Agen, Jan M.S. van Maanen, Frederik-Jan van Schooten & Jos C.S. Kleinjans. (2004) In Vitro and In Vivo Studies on Oxygen Free Radical and DNA Adduct Formation in Rat Lung and Liver during Benzo[a]pyrene Metabolism. Free Radical Research 38:9, pages 995-1002.
Read now
T. Niwa, T. Shiraga, S. Yamasaki, K. Ishibashi, Y. Ohno & A. Kagayama. (2003) In vitro activation of 7-benzyloxyresorufin O-debenzylation and nifedipine oxidation in human liver microsomes. Xenobiotica 33:7, pages 717-729.
Read now
S. Matsumoto, T. Hirama, H. J. Kim, K. Nagata & Y. Yamazoe. (2003) In vitro inhibition of human small intestinal and liver microsomal astemizole O -demethylation: different contribution of CYP2J2 in the small intestine and liver. Xenobiotica 33:6, pages 615-623.
Read now
Gary Carlson. (2003) In Vitro Metabolism of Styrene to Styrene Oxide in Liver and Lung of Cyp2E1 Knockout Mice. Journal of Toxicology and Environmental Health, Part A 66:9, pages 861-869.
Read now
A. M. Belliard, B. Baune, M. Fakhfakh, R. Hocquemiller & R. Farinotti. (2003) Determination of the human cytochrome P450s involved in the metabolism of 2n -propylquinoline. Xenobiotica 33:4, pages 341-355.
Read now
Manoj Bajpai & Joel D. Esmay. (2002) IN VITRO STUDIES IN DRUG DISCOVERY AND DEVELOPMENT: AN ANALYSIS OF STUDY OBJECTIVES AND APPLICATION OF GOOD LABORATORY PRACTICES (GLP). Drug Metabolism Reviews 34:4, pages 679-689.
Read now
Tetsuya Kamataki, Ken-ichi Fujita, Kazuo Nakayama, Yoshiyuki Yamazaki, Masami Miyamoto & Noritaka Ariyoshi. (2002) ROLE OF HUMAN CYTOCHROME P450 (CYP) IN THE METABOLIC ACTIVATION OF NITROSAMINE DERIVATIVES: APPLICATION OF GENETICALLY ENGINEERED SALMONELLA EXPRESSING HUMAN CYP. Drug Metabolism Reviews 34:3, pages 667-676.
Read now
Slobodan Rendic. (2002) Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metabolism Reviews 34:1-2, pages 83-448.
Read now
Z. Yan, G. W. Caldwell, W. N. Wu, L. A. McKown, B. Rafferty, W. Jones & J. A. Masucci. (2002) In vitro identification of metabolic pathways and cytochrome P450 enzymes involved in the metabolism of etoperidone. Xenobiotica 32:11, pages 949-962.
Read now
V. Subrahmanyam, A. B. Renwick, D. G. Walters, R. J. Price, A. P. Tonelli & B. G. Lake. (2002) Metabolism of a novel phosphodiesterase-IV inhibitor (V11294) by human hepatic cytochrome P450 forms. Xenobiotica 32:6, pages 521-534.
Read now
H. Nakajima, T. Nakanishi, H. Naba, K. Nakai, S. Matsumoto, K. Nagasawa, K. Ida, T. Ogihara & N. Ohzawa. (2002) Studies on the metabolic fate of M17055, a novel diuretic (6). Assessment for drug-drug interactions of M17055 in metabolism, distribution and excretion. Xenobiotica 32:12, pages 1161-1172.
Read now
M. S. Ching, C. L. Blake, N. A. Malek, P. W. Angus & H. Ghabrial. (2001) Differential inhibition of human CYP1A1 and CYP1A2 by quinidine and quinine. Xenobiotica 31:11, pages 757-767.
Read now
R. J. Weaver. (2001) Assessment of drug-drug interactions: concepts and approaches. Xenobiotica 31:8-9, pages 499-538.
Read now
J. Hoskins, G. Shenfield, M. Murray & A. Gross. (2001) Characterization of moclobemide N-oxidation in human liver microsomes. Xenobiotica 31:7, pages 387-397.
Read now
A. B. Renwick, D. F. V. Lewis, S. Fulford, D. Surry, B. Williams, P. D. Worboys, X. Cai, R. W. Wang, R. J. Price, B. G. Lake & D. C. Evans. (2001) Metabolism of 2,5-bis(trifluoromethyl)-7-benzyloxy-4-trifluoromethylcoumarin by human hepatic CYP isoforms: evidence for selectivity towards CYP3A4. Xenobiotica 31:4, pages 187-204.
Read now
S. Furuta, E. Kamada, T. Suzuki, T. Sugimoto, Y. Kawabata, Y. Shinozaki & H. Sano. (2001) Inhibition of drug metabolism in human liver microsomes by nizatidine, cimetidine and omeprazole. Xenobiotica 31:1, pages 1-10.
Read now
M. A. M. WENKER, S. KEŽIĆ, A. C. MONSTER & F. A. DE WOLFF. (2001) Metabolism of styrene in the human liver in vitro: interindividual variation and enantioselectivity. Xenobiotica 31:2, pages 61-72.
Read now
S. Ozawa, K. Ohta, A. Miyajima, H. Kurebayashi, M. Sunouchi, M. Shimizu, N. Murayama, Y. Matsumoto, M. Fukuoka & Y. Ohno. (2000) Metabolic activation of o-phenylphenol to a major cytotoxic metabolite, phenylhydroquinone: role of human CYP1A2 and rat CYP2C11/CYP2E1. Xenobiotica 30:10, pages 1005-1017.
Read now
A. B. Renwick, D. Surry, R. J. Price, B. G. Lake & D. C. Evans. (2000) Metabolism of 7-benzyloxy-4-trifluoromethylcoumarin by human hepatic cytochrome P450 isoforms. Xenobiotica 30:10, pages 955-969.
Read now
D. F. V. Lewis, M. G. Bird, M. Dickins, B. G. Lake, P. J. Eddershaw, M. H. Tarbit, P. S. Goldfarb. (2000) Molecular modelling of human CYP2E1 by homology with the CYP102 haemoprotein domain: investigation of the interactions of substrates and inhibitors within the putative active site of the human CYP2E1 isoform. Xenobiotica 30:1, pages 1-25.
Read now
J. J. P. Bogaards, M. Bertrand, P. Jackson, M. J. Oudshoorn, R. J. Weaver, P. J. Van Bladeren & B. Walther. (2000) Determining the best animal model for human cytochrome P450 activities: a comparison of mouse, rat, rabbit, dog, micropig, monkey and man. Xenobiotica 30:12, pages 1131-1152.
Read now
SEAN EKINS & STEVEN A. WRIGHTON. (1999) THE ROLE OF CYP2B6 IN HUMAN XENOBIOTIC METABOLISM*. Drug Metabolism Reviews 31:3, pages 719-754.
Read now
G. C. MOODY. (1999) Fully automated analysis of activities catalysed by the major human liver cytochrome P450 (CYP) enzymes: assessment of human CYP inhibition potential. Xenobiotica 29:1, pages 53-75.
Read now
T. SHIRAGA, H. KANEKO, K. IWASAKI, Z. TOZUKA, A. SUZUKI & T. HATA. (1999) Identification of cytochrome P450 enzymes involved in the metabolism of zotepine, an antipsychotic drug, in human liver microsomes. Xenobiotica 29:3, pages 217-229.
Read now
D. F. V. LEWIS, B. G. LAKE, M. DICKINS, P. J. EDDERSHAW, M. H. TARBIT & P. S. GOLDFARB. (1999) Molecular modelling of CYP2B6, the human CYP2B isoform, by homology with the substrate-bound CYP102 crystal structure: evaluation of CYP2B6 substrate characteristics, the cytochrome b5 binding site and comparisons with CYP2B1 and CYP2B4. Xenobiotica 29:4, pages 361-393.
Read now
M. Nakajima, K. Kobayashi, K. Oshima, N. Shimada, S. Tokudome, K. Chiba & T. Yokoi. (1999) Activation of phenacetin O-deethylase activity by α-naphthoflavone in human liver microsomes. Xenobiotica 29:9, pages 885-898.
Read now
S. M. Raleigh, E. Wanogho, M. D. Burke & L. H. Patterson. (1999) Rat cytochromes P450 (CYP) specifically contribute to the reductive bioactivation of AQ4N, an alkylaminoanthraquinone-di-N-oxide anticancer prodrug. Xenobiotica 29:11, pages 1115-1122.
Read now
C. CHESNE, C. GUYOMARD, A. GUILLOUZO, J. SCHMID, E. LUDWIG & T. SAUTER. (1998) Metabolism of Meloxicam in human liver involves cytochromes P4502C9 and 3A4. Xenobiotica 28:1, pages 1-13.
Read now
A. B. RENWICK, H. MISTRY, S. E. BALL, D. G. WALTERS, J. KAO & B. G. LAKE. (1998) Metabolism of Zaleplon by human hepatic microsomal cytochrome P450 isoforms. Xenobiotica 28:4, pages 337-348.
Read now
GaryP. Carlson. (1997) EFFECTS OF INDUCERS AND INHIBITORS ON THE MICROSOMAL METABOLISM OF STYRENE TO STYRENE OXIDE IN MICE. Journal of Toxicology and Environmental Health 51:5, pages 477-488.
Read now
S. Onof, T. Hatanaka, S. Miyazawa, M. Tsutsui, T. Aoyama, F. J. Gonzalez & T. Satoh. (1996) Human liver microsomal diazepam metabolism using cDNA-expressed cytochrome P450s: Role of CYP2B6, 2C19 and the 3A subfamily. Xenobiotica 26:11, pages 1155-1166.
Read now

Articles from other publishers (157)

Mie Kubota-Sakashita, Hirochika Kawakami, Ko Kikuzato, Fumiyuki Shirai, Takemichi Nakamura & Tadafumi Kato. (2023) An ex vivo screening using mouse brain mitochondria identified seco-cycline D as an inhibitor of mitochondrial permeability transition pore. Biochemical and Biophysical Research Communications, pages 149253.
Crossref
Mawien Karaca, Christian Tobias Willenbockel, Tewes Tralau, Denise Bloch & Philip Marx-Stoelting. (2023) Toxicokinetic and toxicodynamic mixture effects of plant protection products: A case study. Regulatory Toxicology and Pharmacology 141, pages 105400.
Crossref
Xiaoxuan Liu, Qiaoxia Wang, Meng Chen, Jiayue Tao, Jing Wang, Siqi Liu, Jincai Hou, Dan Li & Rufeng Wang. (2023) Interaction between Changan Granule and its main components in the plasma and CYP450 enzymes. Journal of Ethnopharmacology 308, pages 116303.
Crossref
Wenhao Cheng, Kexin Xia, Siyang Wu & Yingfei Li. (2023) Herb-Drug Interactions and Their Impact on Pharmacokinetics: An Update. Current Drug Metabolism 24:1, pages 28-69.
Crossref
Piyusha P. Pagare, Samuel Obeng, Boshi Huang, Madison M. Marcus, Katherine L. Nicholson, Andrew E. Townsend, Matthew L. Banks & Yan Zhang. (2022) Preclinical Characterization and Development on NAQ as a Mu Opioid Receptor Partial Agonist for Opioid Use Disorder Treatment. ACS Pharmacology & Translational Science 5:11, pages 1197-1209.
Crossref
P.M. Burkat. (2022) Physiologically Based Pharmacokinetic and Pharmacodynamic Modeling of Diazepam: Unbound Interstitial Brain Concentrations Correspond to Clinical End Points. The Journal of Clinical Pharmacology 62:10, pages 1297-1309.
Crossref
Marcos Antonio FerreiraJr.Jr., Hatylas Azevedo, Alessandra Mascarello, Natanael Dante Segretti, Elisa Russo, Valter Russo & Cristiano Ruch Werneck Guimarães. (2021) Discovery of ACH-000143 : A Novel Potent and Peripherally Preferred Melatonin Receptor Agonist that Reduces Liver Triglycerides and Steatosis in Diet-Induced Obese Rats . Journal of Medicinal Chemistry 64:4, pages 1904-1929.
Crossref
Josef Skoda, Jan Dusek, Martin Drastik, Alzbeta Stefela, Klara Dohnalova, Karel Chalupsky, Tomas Smutny, Stanislav Micuda, Sabine Gerbal-Chaloin & Petr Pavek. (2020) Diazepam Promotes Translocation of Human Constitutive Androstane Receptor (CAR) via Direct Interaction with the Ligand-Binding Domain. Cells 9:12, pages 2532.
Crossref
Joanna Sniecikowska, Monika Gluch-Lutwin, Adam Bucki, Anna Więckowska, Agata Siwek, Magdalena Jastrzebska-Wiesek, Anna Partyka, Daria Wilczyńska, Karolina Pytka, Gniewomir Latacz, Katarzyna Przejczowska-Pomierny, Elżbieta Wyska, Anna Wesołowska, Maciej Pawłowski, Adrian Newman-Tancredi & Marcin Kolaczkowski. (2020) Discovery of Novel pERK1/2- or β-Arrestin-Preferring 5-HT 1A Receptor-Biased Agonists: Diversified Therapeutic-like versus Side Effect Profile . Journal of Medicinal Chemistry 63:19, pages 10946-10971.
Crossref
Simona Salerno, Franco Tasselli, Enrico Drioli & Loredana De Bartolo. (2020) Poly(ε-Caprolactone) Hollow Fiber Membranes for the Biofabrication of a Vascularized Human Liver Tissue. Membranes 10:6, pages 112.
Crossref
Tiantian Cui, Qian Wang, Xiaoxiao Tian, Kehan Zhang, Ying Peng & Jiang Zheng. (2020) Piperine Is a Mechanism-Based Inactivator of CYP3A. Drug Metabolism and Disposition 48:2, pages 123-134.
Crossref
Waranya Chatuphonprasert, Tharita Kitisripanya, Waraporn Putalun, Isabella Ellinger & Kanokwan Jarukamjorn. (2020) Pueraria candollei var. mirifica-Induced CYP1A1 and CYP1A2 expression in human choriocarcinoma bewo cells. Pharmacognosy Magazine 16:5, pages 506.
Crossref
Roberta Bortolozzi, Davide Carta, Matteo Dal Prà, Giuseppe Antoniazzi, Elena Mattiuzzo, Mattia Sturlese, Veronica Di Paolo, Laura Calderan, Stefano Moro, Ernest Hamel, Luigi Quintieri, Roberto Ronca, Giampietro Viola & Maria Grazia Ferlin. (2019) Evaluating the effects of fluorine on biological properties and metabolic stability of some antitubulin 3-substituted 7-phenyl-pyrroloquinolinones. European Journal of Medicinal Chemistry 178, pages 297-314.
Crossref
Shaoyi Sun, Qi Jia & Zaihui Zhang. (2019) Applications of amide isosteres in medicinal chemistry. Bioorganic & Medicinal Chemistry Letters 29:18, pages 2535-2550.
Crossref
Wim Schelstraete, Laura De Clerck, Elisabeth Govaert, Joske Millecam, Mathias Devreese, Dieter Deforce, Jan Van Bocxlaer & Siska Croubels. (2019) Characterization of Porcine Hepatic and Intestinal Drug Metabolizing CYP450: Comparison with Human Orthologues from A Quantitative, Activity and Selectivity Perspective. Scientific Reports 9:1.
Crossref
Joanna Sniecikowska, Monika Gluch-Lutwin, Adam Bucki, Anna Więckowska, Agata Siwek, Magdalena Jastrzebska-Wiesek, Anna Partyka, Daria Wilczyńska, Karolina Pytka, Krzysztof Pociecha, Agnieszka Cios, Elżbieta Wyska, Anna Wesołowska, Maciej Pawłowski, Mark A. Varney, Adrian Newman-Tancredi & Marcin Kolaczkowski. (2019) Novel Aryloxyethyl Derivatives of 1-(1-Benzoylpiperidin-4-yl)methanamine as the Extracellular Regulated Kinases 1/2 (ERK1/2) Phosphorylation-Preferring Serotonin 5-HT 1A Receptor-Biased Agonists with Robust Antidepressant-like Activity . Journal of Medicinal Chemistry 62:5, pages 2750-2771.
Crossref
Wojciech Słupski, Małgorzata Trocha & Maria Rutkowska. (2017) Pharmacodynamic and pharmacokinetic interactions between simvastatin and diazepam in rats. Pharmacological Reports 69:5, pages 943-952.
Crossref
Tian Lan, Ling-Jing Yuan, Xiao-Xia Hu, Quan Zhou, Jun Wang, Xiang-Xin Huang, Da-Peng Dai, Jian-Ping Cai & Guo-Xin Hu. (2017) Effects of CYP2C19 variants on methadone metabolism in vitro. Drug Testing and Analysis 9:4, pages 634-639.
Crossref
Rebeca Santes-Palacios, Antonio Romo-Mancillas, Rafael Camacho-Carranza & Jesús Javier Espinosa-Aguirre. (2016) Inhibition of human and rat CYP1A1 enzyme by grapefruit juice compounds. Toxicology Letters 258, pages 267-275.
Crossref
D. M. Stresser, E. S. Perloff, A. K. Mason, A. P. Blanchard, S. S. Dehal, T. P. Creegan, R. Singh & E. T. Gangl. (2016) Selective Time- and NADPH-Dependent Inhibition of Human CYP2E1 by Clomethiazole. Drug Metabolism and Disposition 44:8, pages 1424-1430.
Crossref
Shaheed Rehman, Min Choi, In Kim, Zengwei Luo, Yongbo Xue, Guangming Yao, Yonghui Zhang & Hye Yoo. (2016) In Vitro Assessment of CYP-Mediated Drug Interactions for Kinsenoside, an Antihyperlipidemic Candidate. Molecules 21:6, pages 800.
Crossref
Eduardo Esteban-Zubero, Moisés Alejandro Alatorre-Jiménez, Laura López-Pingarrón, Marcos César Reyes-Gonzales, Priscilla Almeida-Souza, Amparo Cantín-Golet, Francisco José Ruiz-Ruiz, Dun-Xian Tan, José Joaquín García & Russel J. Reiter. (2016) Melatonin’s role in preventing toxin-related and sepsis-mediated hepatic damage: A review. Pharmacological Research 105, pages 108-120.
Crossref
Rastislav Jendželovský, Zuzana Jendželovská, Lucia Hiľovská, Ján Kovaľ, Jaromír Mikeš & Peter Fedoročko. (2016) Proadifen sensitizes resistant ovarian adenocarcinoma cells to cisplatin. Toxicology Letters 243, pages 56-66.
Crossref
Margherita Bracchi, David Stuart, Richard Castles, Saye Khoo, David Back & Marta Boffito. (2015) Increasing use of ‘party drugs’ in people living with HIV on antiretrovirals. AIDS 29:13, pages 1585-1592.
Crossref
Mingfei Feng, Hongtu Zhang, Baojun Cao, Shuaidong Liu, Jian Mao & Qidong Zhang. (2015) Effects of 8-methoxypsoralen on the metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mice. Drug Metabolism and Pharmacokinetics 30:4, pages 314-320.
Crossref
Shaheed Ur Rehman, Min Sun Choi, Kevin Choe & Hye Hyun Yoo. (2014) Interactions between herbs and antidiabetics: an overview of the mechanisms, evidence, importance, and management. Archives of Pharmacal Research 38:7, pages 1281-1298.
Crossref
Juhee Sim, Eunhwa Choi, Gil-Saeng Jeong & Sangkyu Lee. (2015) Characterization of in vitro metabolites of cudratricusxanthone A in human liver microsomes . Biopharmaceutics & Drug Disposition 36:5, pages 325-336.
Crossref
Michelle M. Angrish, Michael C. Madden & Joachim D. Pleil. (2015) Probe Molecule (PrM) Approach in Adverse Outcome Pathway (AOP) Based High-Throughput Screening (HTS): In Vivo Discovery for Developing in Vitro Target Methods . Chemical Research in Toxicology 28:4, pages 551-559.
Crossref
B Oxombre, C Lee‐Chang, A Duhamel, M Toussaint, M Giroux, M Donnier‐Maréchal, P Carato, D Lefranc, H Zéphir, L Prin, P Melnyk & P Vermersch. (2015) High‐affinity σ1 protein agonist reduces clinical and pathological signs of experimental autoimmune encephalomyelitis. British Journal of Pharmacology 172:7, pages 1769-1782.
Crossref
Jeongmin Joo, Zhexue Wu, Boram Lee, Jong Cheol Shon, Taeho Lee, In-Kyu Lee, Taebo Sim, Kyung-Hee Kim, Nam Doo Kim, Seong Heon Kim & Kwang-Hyeon Liu. (2015) In vitro metabolism of an estrogen-related receptor γ modulator, GSK5182, by human liver microsomes and recombinant cytochrome P450s . Biopharmaceutics & Drug Disposition 36:3, pages 163-173.
Crossref
Catherine Marcucci & Neil B. Sandson. 2015. A Case Approach to Perioperative Drug-Drug Interactions. A Case Approach to Perioperative Drug-Drug Interactions 389 392 .
Dany Spaggiari, Laurent Geiser, Youssef Daali & Serge Rudaz. (2014) A cocktail approach for assessing the in vitro activity of human cytochrome P450s: An overview of current methodologies. Journal of Pharmaceutical and Biomedical Analysis 101, pages 221-237.
Crossref
Eleni Papagiannidou, Debra J. Skene & Costas Ioannides. (2014) Potential drug interactions with melatonin. Physiology & Behavior 131, pages 17-24.
Crossref
Min Song, HyunHee Do, Oh Kwang Kwon, Eun-Ju Yang, Jong-Sup Bae, Tae Cheon Jeong, Kyung-Sik Song & Sangkyu Lee. (2014) A Comparison of the In Vitro Inhibitory Effects of Thelephoric Acid and SKF-525A on Human Cytochrome P450 Activity. Biomolecules & Therapeutics 22:2, pages 155-160.
Crossref
Marcus Östman, Jerker Fick, Elin Näsström & Richard H. Lindberg. (2014) A snapshot of illicit drug use in Sweden acquired through sewage water analysis. Science of The Total Environment 472, pages 862-871.
Crossref
S. D. Alsharari, E. C. K. Siu, R. F. Tyndale & M. I. Damaj. (2013) Pharmacokinetic and Pharmacodynamics Studies of Nicotine After Oral Administration in Mice: Effects of Methoxsalen, a CYP2A5/6 Inhibitor. Nicotine & Tobacco Research 16:1, pages 18-25.
Crossref
Ikuo Yamamiya, Kunihiro Yoshisue, Yuji Ishii, Hideyuki Yamada & Ken‐ichiro Yoshida. (2013) Enantioselectivity in the cytochrome P450‐dependent conversion of tegafur to 5‐fluorouracil in human liver microsomes. Pharmacology Research & Perspectives 1:1.
Crossref
Aidan Grimsley, Richard Gallagher, Michael Hutchison, Kathryn Pickup, Ian D. Wilson & Kristin Samuelsson. (2013) Drug–drug interactions and metabolism in cytochrome P450 2C knockout mice: Application to troleandomycin and midazolam. Biochemical Pharmacology 86:4, pages 529-538.
Crossref
Tung-Yuan Shih, Ton-Ho Young, Herng-Sheng Lee, Chung-Bao Hsieh & Oliver Yoa-Pu Hu. (2013) Protective Effects of Kaempferol on Isoniazid- and Rifampicin-Induced Hepatotoxicity. The AAPS Journal 15:3, pages 753-762.
Crossref
S.X. Hu. (2013) Effect of age on hepatic cytochrome P450 of Ross 708 broiler chickens. Poultry Science 92:5, pages 1283-1291.
Crossref
Jae-Min Hwang, Taegwon Oh, Takushi Kaneko, Anna M. Upton, Scott G. Franzblau, Zhenkun Ma, Sang-Nae Cho & Pilho Kim. (2013) Design, Synthesis, and Structure–Activity Relationship Studies of Tryptanthrins As Antitubercular Agents. Journal of Natural Products 76:3, pages 354-367.
Crossref
Sanja Dragovic, Patrina Gunness, Magnus Ingelman-Sundberg, Nico P.E. Vermeulen & Jan N. M. Commandeur. (2013) Characterization of Human Cytochrome P450s Involved in the Bioactivation of Clozapine. Drug Metabolism and Disposition 41:3, pages 651-658.
Crossref
Francesco Rua, Giovanna Di Nardo, Sheila J. Sadeghi & Gianfranco Gilardi. (2012) Toward reduction in animal sacrifice for drugs: Molecular modeling of Macaca fascicularis P450 2C20 for virtual screening of Homo sapiens P450 2C8 substrates . Biotechnology and Applied Biochemistry 59:6, pages 479-489.
Crossref
Chia Yong Pang, Joon Wah Mak, Rusli Ismail & Chin Eng Ong. (2012) In vitro modulatory effects of flavonoids on human cytochrome P450 2C8 (CYP2C8). Naunyn-Schmiedeberg's Archives of Pharmacology 385:5, pages 495-502.
Crossref
Chun Li & Nataraj Kalyanaraman. 2012. ADME‐Enabling Technologies in Drug Design and Development. ADME‐Enabling Technologies in Drug Design and Development 189 212 .
Adolfo Sierra-Santoyo, Esperanza Angeles-Soto, Ma. de Lourdes López-González, Randy A. Harrison & Michael F. Hughes. (2011) In vitro metabolism of the anti-androgenic fungicide vinclozolin by rat liver microsomes. Archives of Toxicology 86:3, pages 413-421.
Crossref
David E. Moody. 2012. Handbook of Drug Interactions. Handbook of Drug Interactions 25 116 .
Simona Salerno, Carla Campana, Sabrina Morelli, Enrico Drioli & Loredana De Bartolo. (2011) Human hepatocytes and endothelial cells in organotypic membrane systems. Biomaterials 32:34, pages 8848-8859.
Crossref
Ah-Young Kang, Lindsay R. Young, Carlus Dingfelder & Sabrina Peterson. (2011) Effects of Furanocoumarins from Apiaceous Vegetables on the Catalytic Activity of Recombinant Human Cytochrome P-450 1A2. The Protein Journal 30:7, pages 447-456.
Crossref
Akira Honda, Teruo Miyazaki, Tadashi Ikegami, Junichi Iwamoto, Tomomi Maeda, Takeshi Hirayama, Yoshifumi Saito, Tamio Teramoto & Yasushi Matsuzaki. (2011) Cholesterol 25-hydroxylation activity of CYP3A. Journal of Lipid Research 52:8, pages 1509-1516.
Crossref
Noriyuki Koyama & Yasushi Yamazoe. (2011) Development of Two-dimensional Template System for the Prediction of CYP2B6-mediated Reaction Sites. Drug Metabolism and Pharmacokinetics 26:4, pages 309-330.
Crossref
Masanao Yokohira, Nozomi Hashimoto, Keiko Yamakawa, Kousuke Saoo, Toshiya Kuno & Katsumi Imaida. (2011) Lack of promoting effects from physical pulmonary collapse in a female A/J mouse lung tumor initiated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) with remarkable mesothelial cell reactions in the thoracic cavity by the polymer. Experimental and Toxicologic Pathology 63:1-2, pages 181-185.
Crossref
Wade W. Benton, Adam W. Brothers, Christa C. Jefferis Kirk, Gretchen A. Linggi Irby & Christopher M. Rubino. 2011. Pediatric Critical Care. Pediatric Critical Care 1569 1589 .
Kazuhito Watanabe, Mai Fujinami, Satoshi Yamaori & Ikuo Yamamoto. (2010) Possible involvement of Cyp3a enzymes in the metabolism of tetrahydrocannabinols by mouse brain microsomes. Forensic Toxicology 29:1, pages 56-60.
Crossref
V. A. Sukhanov & L. A. Piruzyan. (2010) Role of physiological factors in predicting the risk of oncological diseases on the basis of the polymorphism of the xenobiotic metabolism enzyme system. Human Physiology 36:6, pages 723-736.
Crossref
Ikuo Yamamiya, Kunihiro Yoshisue, Eiji Matsushima & Sekio Nagayama. (2010) Formation Pathways of γ-Butyrolactone from the Furan Ring of Tegafur during Its Conversion to 5-Fluorouracil. Drug Metabolism and Disposition 38:8, pages 1267-1276.
Crossref
Dongmei Li, Yong Wang, Keli Han & Chang-Guo Zhan. (2010) Fundamental Reaction Pathways for Cytochrome P450-Catalyzed 5′-Hydroxylation and N -Demethylation of Nicotine . The Journal of Physical Chemistry B 114:27, pages 9023-9030.
Crossref
Satoshi Yamaori, Mika Kushihara, Ikuo Yamamoto & Kazuhito Watanabe. (2010) Characterization of major phytocannabinoids, cannabidiol and cannabinol, as isoform-selective and potent inhibitors of human CYP1 enzymes. Biochemical Pharmacology 79:11, pages 1691-1698.
Crossref
Ramesh B. Bambal & Stephen E. Clarke. 2009. Evaluation of Drug Candidates for Preclinical Development. Evaluation of Drug Candidates for Preclinical Development 55 107 .
Sabrina Peterson, Yvonne Schwarz, Shuying S. Li, Lin Li, Irena B. King, Chu Chen, David L. Eaton, John D. Potter & Johanna W. Lampe. (2009) CYP1A2, GSTM1 , and GSTT1 Polymorphisms and Diet Effects on CYP1A2 Activity in a Crossover Feeding Trial . Cancer Epidemiology, Biomarkers & Prevention 18:11, pages 3118-3125.
Crossref
Marta Kot & Władysława A. Daniel. (2009) Effect of diethyldithiocarbamate (DDC) and ticlopidine on CYP1A2 activity and caffeine metabolism: an in vitro comparative study with human cDNA-expressed CYP1A2 and liver microsomes. Pharmacological Reports 61:6, pages 1216-1220.
Crossref
Simona Salerno, Antonella Piscioneri, Stefania Laera, Sabrina Morelli, Pietro Favia, Augustinus Bader, Enrico Drioli & Loredana De Bartolo. (2009) Improved functions of human hepatocytes on NH3 plasma-grafted PEEK-WC–PU membranes. Biomaterials 30:26, pages 4348-4356.
Crossref
Chun Li, Mita Kuchimanchi, Dean Hickman, Leszek Poppe, Mike Hayashi, Yihong Zhou, Raju Subramanian, Gondi Kumar & Sekhar Surapaneni. (2009) In Vitro Metabolism of the Novel, Highly Selective Oral Angiogenesis Inhibitor Motesanib Diphosphate in Preclinical Species and in Humans. Drug Metabolism and Disposition 37:7, pages 1378-1394.
Crossref
Marion Toussaint, Brice Delair, Catherine Foulon, Nadège Lempereur, Claude Vaccher, Tangui Maurice & Patricia Melnyk. (2009) Tic hydantoin sigma-1 agonist: Pharmacological characterization on cocaine-induced stimulant and appetitive effects. European Neuropsychopharmacology 19:7, pages 504-515.
Crossref
Katalin Monostory, Jean-Marc Pascussi, Pál Szabó, Manna Temesvári, Krisztina Köhalmy, Jure Acimovic, Darko Kocjan, Drago Kuzman, Britta Wilzewski, Rita Bernhardt, László Kóbori & Damjana Rozman. (2009) Drug Interaction Potential of 2-((3,4-Dichlorophenethyl)(propyl)amino)-1-(pyridin-3-yl)ethanol (LK-935), the Novel Nonstatin-Type Cholesterol-Lowering Agent. Drug Metabolism and Disposition 37:2, pages 375-385.
Crossref
Martha Estela Salcido-Neyoy, Adolfo Sierra-Santoyo, Olga Beltrán-Ramírez, José Roberto Macías-Pérez & Saúl Villa-Treviño. (2009) Celecoxib enhances the detoxification of diethylnitrosamine in rat liver cancer. World Journal of Gastroenterology 15:19, pages 2345.
Crossref
Kazunobu Aoyama, Kouichi Yoshinari, Hye-Ji Kim, Kiyoshi Nagata & Yasushi Yamazoe. (2009) Simultaneous Expression of Plural Forms of Human Cytochrome P450 at Desired Ratios in HepG2 Cells: Adenovirus-mediated Tool for Cytochrome P450 Reconstitution. Drug Metabolism and Pharmacokinetics 24:3, pages 209-217.
Crossref
Masanao Yokohira, Nozomi Hashimoto, Keiko Yamakawa, Satoshi Suzuki, Kousuke Saoo, Toshiya Kuno & Katsumi Imaida. (2009) Lack of Modifying Effects of Intratracheal Instillation of Quartz or Dextran Sulfate Sodium (DSS) in Drinking Water on Lung Tumor Development Initiated with 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in Female A/J Mice. Journal of Toxicologic Pathology 22:3, pages 179-185.
Crossref
Michael R. Franklin & Laura B. Hathaway. (2008) 2-Diethylaminoethyl-2,2-diphenylvalerate-HCl (SKF525A) Revisited: Comparative Cytochrome P450 Inhibition in Human Liver Microsomes by SKF525A, Its Metabolites, and SKF-Acid and SKF-Alcohol. Drug Metabolism and Disposition 36:12, pages 2539-2546.
Crossref
Annalisa Nannelli, Vera Chirulli, Vincenzo Longo & P. Giovanni Gervasi. (2008) Expression and induction by rifampicin of CAR- and PXR-regulated CYP2B and CYP3A in liver, kidney and airways of pig. Toxicology 252:1-3, pages 105-112.
Crossref
Masanao Yokohira, Hijiri Takeuchi, Kousuke Saoo, Yoko Matsuda, Keiko Yamakawa, Kyoko Hosokawa, Toshiya Kuno & Katsumi Imaida. (2008) Establishment of a bioassay model for lung cancer chemoprevention initiated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in female A/J mice. Experimental and Toxicologic Pathology 60:6, pages 469-473.
Crossref
Luigi Quintieri, Marianna Fantin, Pietro Palatini, Sara De Martin, Antonio Rosato, Michele Caruso, Cristina Geroni & Maura Floreani. (2008) In vitro hepatic conversion of the anticancer agent nemorubicin to its active metabolite PNU-159682 in mice, rats and dogs: A comparison with human liver microsomes. Biochemical Pharmacology 76:6, pages 784-795.
Crossref
J. Riss, J. Cloyd, J. Gates & S. Collins. (2008) Benzodiazepines in epilepsy: pharmacology and pharmacokinetics. Acta Neurologica Scandinavica 118:2, pages 69-86.
Crossref
G. M. Woodward. (2008) The potential effect of excessive coffee consumption on nicotine metabolism: CYP2A6 inhibition by caffeic acid and quercetin. Bioscience Horizons 1:2, pages 98-103.
Crossref
J. O. Straub. 2008. Pharmaceuticals in the Environment. Pharmaceuticals in the Environment 343 383 .
Vera Chirulli, Luigi Marvasi, Anna Zaghini, Roberto Fiorio, Vincenzo Longo & P. Giovanni Gervasi. (2007) Inducibility of AhR-regulated CYP genes by β-naphthoflavone in the liver, lung, kidney and heart of the pig. Toxicology 240:1-2, pages 25-37.
Crossref
Mette T. Skaanild & Christian Friis. (2007) Is Bupropion a More Specific Substrate for Porcine CYP2E than Chlorzoxazone and p-Nitrophenol?. Basic & Clinical Pharmacology & Toxicology 101:3, pages 159-162.
Crossref
Sonia R. Miranda & Sharon A. Meyer. (2007) Cytotoxicity of chloroacetanilide herbicide alachlor in HepG2 cells independent of CYP3A4 and CYP3A7. Food and Chemical Toxicology 45:5, pages 871-877.
Crossref
Kazuhito Watanabe, Satoshi Yamaori, Tatsuya Funahashi, Toshiyuki Kimura & Ikuo Yamamoto. (2007) Cytochrome P450 enzymes involved in the metabolism of tetrahydrocannabinols and cannabinol by human hepatic microsomes. Life Sciences 80:15, pages 1415-1419.
Crossref
Kaori Nakamoto, Judith R. Kidd, Robert D. Jenison, Curtis D. Klaassen, Yu-Jui Yvonne Wan, Kenneth K. Kidd & Xiao-bo Zhong. (2007) Genotyping and haplotyping of CYP2C19 functional alleles on thin-film biosensor chips. Pharmacogenetics and Genomics 17:2, pages 103-114.
Crossref
Sabrina Peterson, Johanna W. Lampe, Theo K. Bammler, Kerstin Gross-Steinmeyer & David L. Eaton. (2006) Apiaceous vegetable constituents inhibit human cytochrome P-450 1A2 (hCYP1A2) activity and hCYP1A2-mediated mutagenicity of aflatoxin B1. Food and Chemical Toxicology 44:9, pages 1474-1484.
Crossref
Malie Rheeders, Marlène Bouwer & Theunis C. Goosen. (2006) Drug-Drug Interaction After Single Oral Doses of the Furanocoumarin Methoxsalen and Cyclosporine. The Journal of Clinical Pharmacology 46:7, pages 768-775.
Crossref
Shizuo Narimatsu, Rei Yonemoto, Keita Saito, Kazuo Takaya, Takuya Kumamoto, Tsutomu Ishikawa, Masato Asanuma, Masahiko Funada, Kimio Kiryu, Shinsaku Naito, Yuzo Yoshida, Shigeo Yamamoto & Nobumitsu Hanioka. (2006) Oxidative metabolism of 5-methoxy-N,N-diisopropyltryptamine (Foxy) by human liver microsomes and recombinant cytochrome P450 enzymes. Biochemical Pharmacology 71:9, pages 1377-1385.
Crossref
Zhimou Wen, May R. Berenbaum & Mary A. Schuler. (2006) Inhibition of CYP6B1-Mediated Detoxification of Xanthotoxin by Plant Allelochemicals in the Black Swallowtail (Papilio polyxenes). Journal of Chemical Ecology 32:3, pages 507-522.
Crossref
Sven Bj??rkman. (2006) Prediction of Cytochrome P450-Mediated Hepatic Drug Clearance in Neonates, Infants and Children. Clinical Pharmacokinetics 45:1, pages 1-11.
Crossref
Wade W. Benton, D. Michael Lindsay, Christopher M. Rubino & Rapheus C.Q. Villanueva. 2006. Pediatric Critical Care. Pediatric Critical Care 1678 1703 .
Anuja Khan, Richard K. Hughes, Eric J. Belfield, Rod Casey, Arthur J. Rowe & Stephen E. Harding. 2006. Analytical Ultracentrifugation VIII. Analytical Ultracentrifugation VIII 116 120 .
C. F. Peet, T. Enos, R. Nave, K. Zech & M. Hall. (2005) Identification of enzymes involved in Phase I metabolism of ciclesonide by human liver microsomes. European Journal of Drug Metabolism and Pharmacokinetics 30:4, pages 275-286.
Crossref
Katalin Monostory, Krisztina Köhalmy, Eszter Hazai, László Vereczkey & László Kóbori. (2005) ROLE OF CYP2E1 IN DERAMCICLANE METABOLISM. Drug Metabolism and Disposition 33:11, pages 1717-1722.
Crossref
Masafumi Miyazaki, Hiroshi Yamazaki, Hijiri Takeuchi, Kousuke Saoo, Masanao Yokohira, Ken-ichi Masumura, Takehiko Nohmi, Yoshihiko Funae, Katsumi Imaida & Tetsuya Kamataki. (2005) Mechanisms of chemopreventive effects of 8-methoxypsoralen against 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung adenomas. Carcinogenesis 26:11, pages 1947-1955.
Crossref
Christian Wolff, Michel Gillard, Bruno Fuks & Pierre Chatelain. (2005) [3H]linopirdine binding to rat brain membranes is not relevant for M-channel interaction. European Journal of Pharmacology 518:1, pages 10-17.
Crossref
Theresa Mariero Klees, Pamela Sheffels, Ola Dale & Evan D. Kharasch. (2005) METABOLISM OF ALFENTANIL BY CYTOCHROME P4503A (CYP3A) ENZYMES. Drug Metabolism and Disposition 33:3, pages 303-311.
Crossref
Luigi Quintieri, Cristina Geroni, Marianna Fantin, Rosangela Battaglia, Antonio Rosato, William Speed, Paola Zanovello & Maura Floreani. (2005) Formation and Antitumor Activity of PNU-159682, A Major Metabolite of Nemorubicin in Human Liver Microsomes. Clinical Cancer Research 11:4, pages 1608-1617.
Crossref
Ram P. Gupta, You Ai He, Kennerly S. Patrick, James R. Halpert & Norman H. Bell. (2005) CYP3A4 Is a Vitamin D-24- and 25-Hydroxylase: Analysis of Structure Function by Site-Directed Mutagenesis. The Journal of Clinical Endocrinology & Metabolism 90:2, pages 1210-1219.
Crossref
Evan D Kharasch, Dale Whittington, Christine Hoffer, Kevin Krudys, Keith Craig, Paolo Vicini, Pam Sheffels & Bojan Lalovic. (2005) Paradoxical Role of Cytochrome P450 3A in the Bioactivation and Clinical Effects of Levo-??-Acetylmethadol. Clinical Pharmacokinetics 44:7, pages 731-751.
Crossref
Chie Emoto, Shigeo Murase, Yasufusa Sawada & Kazuhide Iwasaki. (2005) In Vitro Inhibitory Effect of 1-Aminobenzotriazole on Drug Oxidations in Human Liver Microsomes: a Comparison with SKF-525A. Drug Metabolism and Pharmacokinetics 20:5, pages 351-357.
Crossref
Minoru Tsuda-Tsukimoto, Yuko Ogasawara & Toshiyuki Kume. (2005) Role of Human Liver Cytochrome P450 2C9 in the Metabolism of a Novel α4β1/α4β7 Dual Antagonist, TR-14035. Drug Metabolism and Pharmacokinetics 20:2, pages 127-134.
Crossref
Ram P Gupta, Bruce W Hollis, Shailendra B Patel, Kennerly S Patrick & Norman H Bell. (2003) CYP3A4 is a Human Microsomal Vitamin D 25-Hydroxylase. Journal of Bone and Mineral Research 19:4, pages 680-688.
Crossref
Pi-Lo Tsai & Tung-Hu Tsai. (2004) HEPATOBILIARY EXCRETION OF BERBERINE. Drug Metabolism and Disposition 32:4, pages 405-412.
Crossref
Guillermo Gervasini, Juan Antonio Carrillo & Julio Benitez. (2004) Potential Role of Cerebral Cytochrome P450 in Clinical Pharmacokinetics. Clinical Pharmacokinetics 43:11, pages 693-706.
Crossref
David E. Moody. 2004. Handbook of Drug Interactions. Handbook of Drug Interactions 3 88 .
Julia Kirchheiner, Christian Klein, Ingolf Meineke, Johanna Sasse, Ulrich M Zanger, Thomas E M??rdter, Ivar Roots & J??rgen Brockm??ller. (2003) Bupropion and 4-OH-bupropion pharmacokinetics in relation to genetic polymorphisms in CYP2B6. Pharmacogenetics 13:10, pages 619-626.
Crossref
Graeme B. J. Smith, John R. Bend, Leanne L. Bedard, Ken R. Reid, Dimitri Petsikas & Thomas E. Massey. (2003) BIOTRANSFORMATION OF 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE (NNK) IN PERIPHERAL HUMAN LUNG MICROSOMES. Drug Metabolism and Disposition 31:9, pages 1134-1141.
Crossref
David C. Evans, Desmond O'Connor, Brian G. Lake, Raymond Evers, Christopher Allen & Richard Hargreaves. (2003) ELETRIPTAN METABOLISM BY HUMAN HEPATIC CYP450 ENZYMES AND TRANSPORT BY HUMAN P-GLYCOPROTEIN. Drug Metabolism and Disposition 31:7, pages 861-869.
Crossref
Mikko Niemi, Janne T Backman, Martin F Fromm, Pertti J Neuvonen & Kari T Kivist??. (2003) Pharmacokinetic Interactions with Rifampicin. Clinical Pharmacokinetics 42:9, pages 819-850.
Crossref
M. Teresa Donato & Jos?? V. Castell. (2003) Strategies and Molecular Probes to Investigate the Role of Cytochrome P450 in Drug Metabolism. Clinical Pharmacokinetics 42:2, pages 153-178.
Crossref
H-J Xie, Ü Yasar, S Lundgren, L Griskevicius, Y Terelius, M Hassan & A Rane. (2003) Role of polymorphic human CYP2B6 in cyclophosphamide bioactivation. The Pharmacogenomics Journal 3:1, pages 53-61.
Crossref
Tony Antoniou & Alice Lin-In Tseng. (2016) Interactions between Recreational Drugs and Antiretroviral Agents. Annals of Pharmacotherapy 36:10, pages 1598-1613.
Crossref
Shigeru Furuta, Nobuyoshi Akagawa, Emiko Kamada, Akio Hiyama, Yoshihiro Kawabata, Nobuhiko Kowata, Atsuhiro Inaba, Anne Matthews, Michael Hall & Tadashi Kurimoto. (2002) Involvement of CYP2C9 and UGT2B7 in the metabolism of zaltoprofen, a nonsteroidal anti‐inflammatory drug, and its lack of clinically significant CYP inhibition potential. British Journal of Clinical Pharmacology 54:3, pages 295-303.
Crossref
Gary P Carlson. (2002) Effect of the inhibition of the metabolism of 4-vinylphenol on its hepatotoxicity and pneumotoxicity in rats and mice. Toxicology 179:1-2, pages 129-136.
Crossref
Matthias Pirlich, Cornelia Müller, Grit Sandig, Manuela Jakstadt, Nicolle Sitte, Herbert Lochs & Tilman Grune. (2002) Increased proteolysis after single-dose exposure with hepatotoxins in HepG2 cells. Free Radical Biology and Medicine 33:2, pages 283-291.
Crossref
Marie Stiborová, Lucie Bořek-Dohalská, Petr Hodek, Jaroslav Mráz & Eva Frei. (2002) New selective inhibitors of cytochromes P450 2B and their application to antimutagenesis of tamoxifen. Archives of Biochemistry and Biophysics 403:1, pages 41-49.
Crossref
J.‐S. Chen, M. R. Berenbaum & M. A. Schuler. (2002) Amino acids in SRS1 and SRS6 are critical for furanocoumarin metabolism by CYP6B1v1, a cytochrome P450 monooxygenase. Insect Molecular Biology 11:2, pages 175-186.
Crossref
Hisashi Suzuki, M. Byron Kneller, Robert L. Haining, William F. Trager & Allan E. Rettie. (2002) (+)- N -3-Benzyl-Nirvanol and (−)- N -3-Benzyl-Phenobarbital: New Potent and Selective in Vitro Inhibitors of CYP2C19 . Drug Metabolism and Disposition 30:3, pages 235-239.
Crossref
Kaoru Kobayashi, Kikuko Urashima, Noriaki Shimada & Kan Chiba. (2002) Substrate specificity for rat cytochrome P450 (CYP) isoforms: screening with cDNA-expressed systems of the rat. Biochemical Pharmacology 63:5, pages 889-896.
Crossref
Ute M. Kent, Danielle E. Mills, Rajendram V. Rajnarayanan, William L. Alworth & Paul F. Hollenberg. (2002) Effect of 17-α-Ethynylestradiol on Activities of Cytochrome P450 2B (P450 2B) Enzymes: Characterization of Inactivation of P450s 2B1 and 2B6 and Identification of Metabolites. Journal of Pharmacology and Experimental Therapeutics 300:2, pages 549-558.
Crossref
Michael Zschiesche, Girum Lakew Lemma, Klaus‐Jürgen Klebingat, Gerd Franke, Bernd Terhaag, Anna Hoffmann, Thomas Gramatté, Heyo K. Kroemer & Werner Siegmund. (2002) Stereoselective disposition of talinolol in man. Journal of Pharmaceutical Sciences 91:2, pages 303-311.
Crossref
Hiroyuki Nakajima, Takeshi Nakanishi, Kiyohiko Nakai, Shigeki Matsumoto, Keiichi Ida, Takuo Ogihara & Nobuo Ohzawa. (2002) Studies on the Metabolic Fate of M17055 a Novel Diuretic (4): Species Difference in Metabolic Pathway and Identification of Human CYP Isoform Responsible for the Metabolism of M17055. Drug Metabolism and Pharmacokinetics 17:1, pages 60-74.
Crossref
Kazuhito Watanabe, Tamihide Matsunaga, Toshiyuki Kimura, Tatsuya Funahashi, Yoshihiko Funae, Tohru Ohshima & Ikuo Yamamoto. (2002) Major Cytochrome P450 Enzymes Responsible for Microsomal Aldehyde Oxygenation of 11-Oxo-Δ8-tetrahydrocannabinol and 9-Anthraldehyde in Human Liver. Drug Metabolism and Pharmacokinetics 17:6, pages 516-521.
Crossref
Takashi Matsubara. (2002) Safety Evaluation and Drug Development based on Biological Fate of Drugs —Efforts Made to Overcome Drug Interaction in Drug Development—. Drug Metabolism and Pharmacokinetics 17:5, pages 379-394.
Crossref
Ulrich M. Zanger, Joachim Fischer, Kathrin Klein & Thomas Lang. 2002. Cytochrome P450 Part C. Cytochrome P450 Part C 45 53 .
Mark W Powley & Gary P Carlson. (2001) Hepatic and pulmonary microsomal benzene metabolism in CYP2E1 knockout mice. Toxicology 169:3, pages 187-194.
Crossref
Karthik Venkatakrishnan, Lisa L. von Moltke & David J. Greenblatt. (2013) Human Drug Metabolism and the Cytochromes P450: Application and Relevance of In Vitro Models. The Journal of Clinical Pharmacology 41:11, pages 1149-1179.
Crossref
Shinichi Inomata, Einosuke Tanaka, Masayuki Miyabe, Yoshihiro Kakiuchi, Atsushi Nagashima, Yuichiro Yamasaki, Shin Nakayama, Yasuyuki Baba, Hidenori Toyooka, Kazuhiko Okuyama & Yukinao Kohda. (2001) Plasma Lidocaine Concentrations During Continuous Thoracic Epidural Anesthesia After Clonidine Premedication in Children. Anesthesia & Analgesia 93:5, pages 1147-1151.
Crossref
Mark W Powley & Gary P Carlson. (2001) Cytochrome P450 isozymes involved in the metabolism of phenol, a benzene metabolite. Toxicology Letters 125:1-3, pages 117-123.
Crossref
Giada Amato, Emanuela Grasso, Vincenzo Longo & Pier Giovanni Gervasi. (2001) Oxidation of N,N-dimethylformamide and N,N-diethylformamide by human liver microsomes and human recombinant P450s. Toxicology Letters 124:1-3, pages 11-19.
Crossref
Akira Honda, Gerald Salen, Yasushi Matsuzaki, Ashok K. Batta, Guorong Xu, Eran Leitersdorf, G.Stephen Tint, Sandra K. Erickson, Naomi Tanaka & Sarah Shefer. (2001) Side Chain Hydroxylations in Bile Acid Biosynthesis Catalyzed by CYP3A Are Markedly Up-regulated in Cyp27 Mice but Not in Cerebrotendinous Xanthomatosis. Journal of Biological Chemistry 276:37, pages 34579-34585.
Crossref
Thomas Lang, Kathrin Klein, Joachim Fischer, Andreas Nussler, Peter Neuhaus, Ute Hofmann, Michel Eichelbaum, Matthias Schwab & Ulrich Zanger. (2001) Pharmacogenetics 11:5, pages 399-415.
Crossref
I. Tantcheva-Poor, M. Servera-Llaneras, K. Scharffetter-Kochanek & U. Fuhr. (2001) Liver cytochrome P450 CYP1A2 is markedly inhibited by systemic but not by bath PUVA in dermatological patients. British Journal of Dermatology 144:6, pages 1127-1132.
Crossref
Zeqi Huang & David J Waxman. (2001) Modulation of cyclophosphamide-based cytochrome P 450 gene therapy using liver P450 inhibitors. Cancer Gene Therapy 8:6, pages 450-458.
Crossref
Lina Long, Robert C. Moschel & M.Eileen Dolan. (2001) Debenzylation of O6-benzyl-8-oxoguanine in human liver: implications for O6-benzylguanine metabolism. Biochemical Pharmacology 61:6, pages 721-726.
Crossref
Noritaka Ariyoshi, Masafumi Miyazaki, Kenji Toide, Yu-ichi Sawamura & Tetsuya Kamataki. (2001) A Single Nucleotide Polymorphism of CYP2B6 Found in Japanese Enhances Catalytic Activity by Autoactivation. Biochemical and Biophysical Research Communications 281:5, pages 1256-1260.
Crossref
Shigeki Matsumoto & Yasushi Yamazoe. (2008) Involvement of multiple human cytochromes P450 in the liver microsomal metabolism of astemizole and a comparison with terfenadine. British Journal of Clinical Pharmacology 51:2, pages 133-142.
Crossref
G. Gervasini, C. Martinez, J. Agundez, F. Garcia-Gamito & J. Benitez. (2001) Pharmacogenetics 11:1, pages 29-37.
Crossref
Pascal Bonnabry, Johann Sievering, Thierry Leemann & Pierre Dayer. (2001) Quantitative Drug Interactions Prediction System (Q-DIPS). Clinical Pharmacokinetics 40:9, pages 631-640.
Crossref
Ken‐ichi Fujita, Kazuo Nakayama, Yoshiyuki Yamazaki, Kazuhiro Tsuruma, Masami Yamada, Takehiko Nohmi & Tetsuya Kamataki. (2001) Construction of Salmonella typhimurium YG7108 strains, each coexpressing a form of human cytochrome P450 with NADPH–cytochrome P450 reductase . Environmental and Molecular Mutagenesis 38:4, pages 329-338.
Crossref
Chin‐Eng Ong, Sally Coulter, Donald J. Birkett, C. Ramana Bhasker & John O. Miners. (2008) The xenobiotic inhibitor profile of cytochrome P4502C8. British Journal of Clinical Pharmacology 50:6, pages 573-580.
Crossref
Shuji Ohhira, Hisao Matsui & Keita Watanabe. (2000) Effects of pretreatment with SKF-525A on triphenyltin metabolism and toxicity in mice. Toxicology Letters 117:3, pages 145-150.
Crossref
A Buschini, E Anceschi, C Carlo-Stella, E Regazzi, V Rizzoli, P Poli & C Rossi. (2000) Amifostine (WR-2721) selective protection against melphalan genotoxicity. Leukemia 14:9, pages 1642-1651.
Crossref
Helen C. Rawden, Gilbert O. Kokwaro, Stephen A. Ward & Geoffrey Edwards. (2000) Relative contribution of cytochromes P-450 and flavin-containing monoxygenases to the metabolism of albendazole by human liver microsomes. British Journal of Clinical Pharmacology 49:4, pages 313-322.
Crossref
H Bohets, K Lavrijsen, J Hendrickx, J Van Houdt, V Van Genechten, P Verboven, W Meuldermans & J Heykants. (2009) Identification of the cytochrome P450 enzymes involved in the metabolism of cisapride: in vitro studies of potential co‐medication interactions . British Journal of Pharmacology 129:8, pages 1655-1667.
Crossref
Karthik Venkatakrishnan, Lisa L. von Moltke & David J. Greenblatt. (2000) Effects of the Antifungal Agents on Oxidative Drug Metabolism. Clinical Pharmacokinetics 38:2, pages 111-180.
Crossref
Mark W. Powley & Gary P. Carlson. (2000) Cytochromes P450 involved with benzene metabolism in hepatic and pulmonary microsomes. Journal of Biochemical and Molecular Toxicology 14:6, pages 303-309.
Crossref
David F.V. Lewis, Brian G. Lake, Stephen G. George, Maurice Dickins, Peter J. Eddershaw, Michael H. Tarbit, Alan P. Beresford, Peter S. Goldfarb & F.Peter Guengerich. (1999) Molecular modelling of CYP1 family enzymes CYP1A1, CYP1A2, CYP1A6 and CYP1B1 based on sequence homology with CYP102. Toxicology 139:1-2, pages 53-79.
Crossref
Yi Wang & Jashvant D. Unadkat. (1999) Enzymes in addition to CYP3A4 and 3A5 mediateN-demethylation of dextromethorphan in human liver microsomes. Biopharmaceutics & Drug Disposition 20:7, pages 341-346.
Crossref
W. Zhang, H. Parentau, R. L. Greenly, C. A. Metz, S. Aggarwal, I. W. Wainer & T. S. Tracy. (1999) Effect of protein-calorie malnutrition on cytochromes P450 and glutathione S-transferase. European Journal of Drug Metabolism and Pharmacokinetics 24:2, pages 141-147.
Crossref
Meera Tugnait, Edward M. Hawes, Gordon McKay, Michel Eichelbaum & Kamal K. Midha. (1999) Characterization of the human hepatic cytochromes P450 involved in the in vitro oxidation of clozapine. Chemico-Biological Interactions 118:2, pages 171-189.
Crossref
D.F.V Lewis, M Dickins, B.G Lake, P.J Eddershaw, M.H Tarbit & P.S Goldfarb. (1999) Molecular modelling of the human cytochrome P450 isoform CYP2A6 and investigations of CYP2A substrate selectivity. Toxicology 133:1, pages 1-33.
Crossref
Catrin Furster & Kjell Wikvall. (1999) Identification of CYP3A4 as the major enzyme responsible for 25-hydroxylation of 5β-cholestane-3α,7α,12α-triol in human liver microsomes. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1437:1, pages 46-52.
Crossref
Matt J Cheesman & Paul E.B Reilly. (1998) Differential inducibility of specific mRNA corresponding to five CYP3A isoforms in female rat liver by RU486 and food deprivation. Biochemical Pharmacology 56:4, pages 473-481.
Crossref
Karthik Venkatakrishnan, Lisa L. von Moltke & David J. Greenblatt. (1998) Relative Quantities of Catalytically Active CYP 2C9 and 2C19 in Human Liver Microsomes: Application of the Relative Activity Factor Approach. Journal of Pharmaceutical Sciences 87:7, pages 845-853.
Crossref
Evan D. Kharasch, Douglas C. Hankins, Pamela J. Baxter & Kenneth E. Thummel. (1998) Single-dose disulfiram does not inhibit CYP2A6 activity*. Clinical Pharmacology & Therapeutics 64:1, pages 39-45.
Crossref

Displaying 200 of 205 citing articles. Use the download link below to view the full list of citing articles.

Download full citations list

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.